Fundalysisby DARKHORSESTOCKS

Scheme

Tata India Pharma Healthcare Fund

Holds 42 companies worth ₹1,507 Cr in Sept 2026.

  • Fund house

    TataThe fund house that runs this scheme.

  • AUM

    Not reportedAMFI reports no AUM for it.

  • Largest holding

    Sun Pharmaceutical Ind LtdSun Pharmaceutical Ind Ltd is 8.0% of this scheme's NAV.

  • Fund manager

    Rajat SrivastavaRuns it since 16 Sept 2024, as the fund house dates it.

Overview(9 Oct 2026)

Fund managers1

  1. Rajat SrivastavaFund manager · Sept 2024 · 9y · PGDM
  1. Meeta ShettyMar 2021 – Jul 2025

Key facts

Benchmark
BSE Healthcare TRI
Risk
Very High
Expense
Regular 2.37% · Direct 1.07%
Exit load
0.25% within 30 days
Started
28 Dec 2015
Minimum
₹5,000

Source.Its Scheme Summary Document as of 9 Oct 2026 at AMFI.

What changed(10 changes)

Sept 2026

1 change
  1. Expense ratio
    11 SeptRegular 2.28% → 2.32%Direct 0.97% → 1%

Aug 2026

1 change
  1. Expense ratio
    13 AugRegular 2.18% → 2.28%Direct 0.79% → 0.97%

Apr 2026

1 change
  1. Expense ratio
    29 AprRegular 2.11% → 2.18%Direct 0.69% → 0.79%

Source.Its filings at NSE, since Mar 2025.

Fund managers over time(Mar 2021 – now)

  1. Rajat Srivastava
  2. Meeta Shetty
MainCoSlice20222023202420252026
Fig. 1.Who ran it when: each manager from the date the fund house gives, or the first document listing them where it gives none, to when they left. A slice is part of it: overseas, gold and silver, or arbitrage.

Costs(Mar 2025 – Oct 2026)

Every change to the expense ratio, newest first.
9 changesRegularDirectΔ pt
11 Sept 20262.32%1.00%0.03
13 Aug 20262.28%0.97%0.18
29 Apr 20262.18%0.79%0.10
27 Feb 20262.11%0.69%0.08
30 Dec 20252.10%0.61%0.01
31 Aug 20252.10%0.62%0.01
31 Jul 20252.10%0.61%0.02
30 Jun 20252.11%0.63%0
31 Mar 20252.12%0.63%–
Direct plan, 11 Sept 2026
1.00%
Regular plan 2.32% · Exit load 0.25% within 30 days
Fig. 1.Total expense ratio a year, each plan's, as its Scheme Summary Documents state it, filing by filing at NSE. A change holds until the next.

Objective and risk(9 Oct 2026)

Objective

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.

Risk, type and benchmark

Riskometer
Very High
At launch
Very High
Type
An open ended equity scheme investing in Pharma and Healthcare Services Sector.
Benchmark
BSE Healthcare TRI

Asset allocation it may hold% of NAV

  1. Equity & equity related instruments of companies in the Pharma & Healthcare Sectors
    Allowed80–100%
  2. Other Equity/Equity related instruments
    Allowed0–20%
  3. Money Market Instruments, other liquid instruments**, gold and/or silver instruments/ETF, InvITs as permitted by SEBI
    Allowed0–20%

Holds in Sept 2026.99.7% equity · 0.3% debt and cash

How to invest(9 Oct 2026)

Buying

To start
₹5,000, then in multiples of ₹1
To add
₹1,000, then in multiples of ₹1
Most
Not Applicable.
Systematic
SIP-- Monthly/Monthly/Quarterly/Quarterly/Weekly/Daily (Business Days) ;STP --Monthly/Quarterly/Weekly/Daily (Business Days) ;SWP --Monthly/Quarterly/Half-yearly/Yearly
Dates
SIP-- Any day/Any day/Any day/Any day/Monday-Friday/All Business Days ;STP --Any day/Any day/Monday-Friday/All Business Days ;SWP --Any day/Any day/Any day/Any day
Minimum
SIP-- 100.00/100.00/100.00/100.00/100.00/100.00 ;STP --500.00/500.00/500.00/500.00 ;SWP --500.00/500.00/500.00/500.00, then sIP-- 1.00/1.00/1.00/1.00/1.00/1.00 ;STP --1.00/1.00/1.00/1.00 ;SWP --1.00/1.00/1.00/1.00
Instalments
SIP-- 12 Instalments/6 instalments/6 instalments/4 instalments/12 instalments/12 instalments ;STP --500.00 to 999.00 - 12 instalments; 1,000.00 to 1,999.00 - 6 instalments; 2,000.00 and more - 3 instalments ;SWP --1.00/1.00/1.00/1.00
Most
SIP-- 999.00/Not Applicable/Not Applicable/Not Applicable/Not Applicable/Not Applicable ;STP --Not Applicable/Not Applicable/Not Applicable/Not Applicable ;SWP --Not Applicable/Not Applicable/Not Applicable/Not Applicable

Selling and switching

To redeem
₹500 or 50 units
Switch minimum
For all units there is no minimum switch amount. or For all units there is no minimum switch units. units
Switch multiples
Not Applicable. or Not Applicable. units
Switch most
Not Applicable. or Not Applicable. units

Scheme details(9 Oct 2026)

What it is

Category
Sectoral Fund
Offer
4 Dec 2015 to 8 Dec 2015
Started
28 Dec 2015
Reopened
29 Dec 2015
Plans
Tata India Pharma and Healthcare Fund Regular Plan IDCW · Tata India Pharma and Healthcare Fund Direct Plan IDCW · Tata India Pharma and Healthcare Fund Regular Plan Growth · Tata India Pharma and Healthcare Fund Direct Plan Growth
Face value
₹10
Listed
No

How it is run

Swing pricing
No
Side-pocketing
Yes
Custodian
Standard Chartered Bank
Auditor
S.R. Batliboi & CO. LLP
Registrar
Computer Age Management Services Limited
SEBI code
TATA/O/E/SEC/15/10/0027